Check our latest news and where we are going to be soon.

310, 2022

The TRANSBIO study demonstrates the usefulness of Immunobiogram® for predicting the response to different immunosuppressive treatments in transplant recipients

The results have been published in the high-impact journal Transplant immunology. TRANSBIO, a multicenter, international clinical study, has demonstrated the correlation of the in-vitro measurement of the patient's pharmacodynamic response to immunosuppressive drugs, using the Immunobiogram® diagnostic [...]

2211, 2021

Immunobiogram® has been granted a US patent by USPTO

Biohope´s lead product, the Immunobiogram®, has been granted a US patent by the United States Patent and Trademark Office. This new patent complements and consolidates  Biohope´s  intellectual property protection facilitating the commercial expansion in a key market [...]